✦ LIBER ✦

Sorafenib as treatment for relapsed or refractory pediatric acute myelogenous leukemia

✍ Scribed by Tanya C. Watt; Todd Cooper

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of relapsed and refractory acu

✍ Estey, E H 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 82 KB

Treatment of relapsed or refractory acut

✍ Martin S. Tallman 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Mitoxantrone and etoposide: An effective

✍ M. Lazzarino; E. Morra; E. P. Alessandrino; E. Orlandi; G. Pagnucco; S. Merante; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB

Treatment of relapsed or refractory adul

✍ Mathias Freund; Helmut Diedrich; Arnold Gamer; Martin Gramatzki; Gerhard Heil; A 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 645 KB

Comparison of fludarabine-containing sal

✍ Thomas, M B; Koller, C; Yang, Y; Shen, Y; O'Brien, S; Kantarjian, H; Davis, J; E 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 109 KB

Prognostic factors for outcomes of patie

✍ Raymond Wong; Munir Shahjahan; Xuemei Wang; Peter F. Thall; Marcos de Lima; Issa 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 183 KB